JS

Jean-Pierre Sommadossi

IP Idenix Pharmaceuticals: 37 patents #1 of 67Top 2%
UC Università Degli Studi Di Cagliari: 23 patents #1 of 61Top 2%
AP Atea Pharmaceuticals: 23 patents #1 of 4Top 25%
CN CNRS: 16 patents #33 of 11,908Top 1%
LI L'Universite Montpellier Ii: 8 patents #2 of 12Top 20%
EU Emory University: 8 patents #51 of 1,217Top 5%
TF The Uab Research Foundation: 7 patents #36 of 813Top 5%
TF The University Of Alabama Research Foundation: 2 patents #4 of 32Top 15%
UG University Of Georgia: 2 patents #194 of 915Top 25%
NA Novartis Ag: 2 patents #1,923 of 5,128Top 40%
BU Brown University: 1 patents #98 of 201Top 50%
UM Universite De Montpellier: 1 patents #213 of 699Top 35%
UB University Of Alabama At Birmingham: 1 patents #8 of 34Top 25%
UN Unknown: 1 patents #29,356 of 83,584Top 40%
C. C.N.R.S.: 1 patents #27 of 220Top 15%
📍 Boston, MA: #24 of 5,993 inventorsTop 1%
🗺 Massachusetts: #395 of 88,656 inventorsTop 1%
Overall (All Time): #21,932 of 4,157,543Top 1%
81
Patents All Time

Issued Patents All Time

Showing 51–75 of 81 patents

Patent #TitleCo-InventorsDate
7384924 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Paola LaColla, Richard Storer, Gilles Gosselin 2008-06-10
7365090 Substituted phenylindoles for the treatment of HIV Marino Artico, Paolo LaColla, Romano Silvestri, Adel Moussa, Richard Storer 2008-04-29
7365057 Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections Paola LaColla, Richard Storer, Gilles Gosselin 2008-04-29
7192936 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections Paola LaColla, Richard Storer, Gilles Gosselin 2007-03-20
7186700 β-L-2′-deoxynucleosides for the treatment of resistant HBV strains and combination therapies David Standring, April L. Patty, Maria Seifer 2007-03-06
7169766 Methods and compositions for treating hepatitis C virus Paulo LaColla 2007-01-30
7163929 Methods and compositions for treating flaviviruses and pestiviruses Paulo LaColla 2007-01-16
7157441 Methods and compositions for treating hepatitis C virus Paulo LaColla 2007-01-02
7148206 Methods and compositions for treating flaviviruses and pestiviruses Paulo LaColla 2006-12-12
7138376 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides Gilles Gosselin, Jean-Louis Imbach 2006-11-21
7105493 Methods and compositions for treating flaviviruses and pestiviruses Paulo LaColla 2006-09-12
7101861 Methods and compositions for treating flaviviruses and pestiviruses Paulo LaColla 2006-09-05
6914054 Methods and compositions for treating hepatitis C virus Paulo LaColla 2005-07-05
6896900 β-L-2'-deoxy-nucleosides for the treatment of HIV infection Gilles Gosselin, Jean-Louis Imbach, Raymond F. Schinazi 2005-05-24
6812219 Methods and compositions for treating flaviviruses and pestiviruses Paulo LaColla 2004-11-02
6787526 Methods of treating hepatitis delta virus infection with &bgr;-L-2′-deoxy-nucleosides Martin Bryant 2004-09-07
6710068 Phenylindoles for the treatment of HIV Paulo LaColla, Marino Artico 2004-03-23
6596700 Methods of treating hepatitis delta virus infection with &bgr;-L-2'-deoxy-nucleosides Martin Bryant 2003-07-22
6545007 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines Martin Bryant, Marino Artico, Paolo La Colla 2003-04-08
6525033 Nucleosides with anti-hepatitis B virus activity Raymond F. Schinazi, Gilles Gosselin, Jean-Louis Imbach 2003-02-25
6458773 Nucleoside with anti-hepatitis B virus activity Gilles Gosselin, Jean-Louis Imbach, Raymond F. Schinazi 2002-10-01
6407077 &bgr;-L nucleosides for the treatment of HIV infection Gilles Gosselin, Jean-Louis Imbach, Raymond F. Schinazi 2002-06-18
6245749 Nucleosides with anti-hepatitis B virus activity Raymond F. Schinazi, Gilles Gosselin, Jean-Louis Imbach 2001-06-12
5990093 Treating HBV with phospholipid prodrugs of .beta.-L-2',3'-dideoxyadenosine 5'-monophosphate Raymond F. Schinazi, Gilles Gosselin, Jean-Louis Imbach 1999-11-23
5750493 Method to improve the biological and antiviral activity of protease inhibitors Raymond F. Schinazi 1998-05-12